Published: Jun 01, 2021, 21:10 IST | Updated: Jun 01, 2021, 21:10 IST
India’s apex drug regulator has announced that foreign vaccines like Pfizer and Moderna will no longer have to clear India-specific trials. The Drug Controller General of India (DCGI) has done away with such requirements in order to speed up vaccine imports.